Quote | Super Quote
Security Code
Company Name (Chi/Eng/Keywords)
Industry
SDI
More
09/04/2026
Code & Name Shareholder
02315
BIOCYTOGEN-B
InnoVeda Medtech, Ltd.
02772
ZLKG
Yang Jian
02005
SSY GROUP
Qu Jiguang
02005
SSY GROUP
China Pharmaceutical Company Limited
08/04/2026
Code & Name Total Fund Raised
01088
CHINA SHENHUA
RMB 20.000B
08/04/2026
Code & Name Total Paid
00797
7ROAD
HKD 1,460
01299
AIA
HKD 198,884,859
02373
BEAUTYFARM MED
HKD 905,105
06993
BLUE MOON GROUP
HKD 2,362,615
Date Main Board Total Value ($) Main Borad Turnover
10/04/2026 39.876B --
09/04/2026 45.185B --
08/04/2026 62.817B --
02/04/2026 53.506B --
Result Announcements
01773TIANLI INT HLDG
Economic Figures
Germany: Feb Current Account
New Zealand: Mar Manufacturing PMI
Japan: Mar PPI
11/04/2026 (Sat)
Russia: Mar CPI
13/04/2026 (Mon)
New Zealand: Mar Performance of Service Index
14/04/2026 (Tue)
China: Mar Export
More
Code Name Register Close Listing Date Offer Price
00068MANYCORE TECH2026/04/142026/04/176.72 - 7.62
03277GPIXEL2026/04/142026/04/1739.88
06656SIGENERGY2026/04/132026/04/16324.20
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.